Vaping, JUUL and E-Cigarettes: A Public Health Crisis James - - PowerPoint PPT Presentation

vaping juul and e cigarettes a public health crisis
SMART_READER_LITE
LIVE PREVIEW

Vaping, JUUL and E-Cigarettes: A Public Health Crisis James - - PowerPoint PPT Presentation

Vaping, JUUL and E-Cigarettes: A Public Health Crisis James Latronica, D.O. Anthony Dekker, D.O. American Osteopathic Association of Addiction Medicine Disclosure Neither presenter has any conflicts of interest or disclosures to address


slide-1
SLIDE 1

Vaping, JUUL and E-Cigarettes: A Public Health Crisis

James Latronica, D.O. Anthony Dekker, D.O.

American Osteopathic Association of Addiction Medicine

slide-2
SLIDE 2

Disclosure

  • Neither presenter has any conflicts of interest
  • r disclosures to address
slide-3
SLIDE 3
slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10
slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14

JUUL is not alone…

slide-15
SLIDE 15

What’s In a JUUL Pod?

slide-16
SLIDE 16
slide-17
SLIDE 17
slide-18
SLIDE 18
slide-19
SLIDE 19
slide-20
SLIDE 20
slide-21
SLIDE 21
slide-22
SLIDE 22
slide-23
SLIDE 23
slide-24
SLIDE 24
slide-25
SLIDE 25

Lung Injury

slide-26
SLIDE 26

Lung Injury

slide-27
SLIDE 27
slide-28
SLIDE 28

E-Cigarettes As Smoking Cessation

slide-29
SLIDE 29

The “Harm Reduction” Aspect

slide-30
SLIDE 30

SUD and Tobacco

slide-31
SLIDE 31

SUD and Tobacco

slide-32
SLIDE 32
slide-33
SLIDE 33
slide-34
SLIDE 34
slide-35
SLIDE 35
slide-36
SLIDE 36
slide-37
SLIDE 37
slide-38
SLIDE 38
slide-39
SLIDE 39
  • Juul
  • $1.2 Billion sales

(Jan – Jun 2019)

  • 2016-- 2.2 million

units

  • 2017-- 16.2 million

units

Profit Incentive

slide-40
SLIDE 40

Profit Incentive

  • James Monsees (39)

and Adam Bowen (44)

  • Stanford University --

smoke break 2005

  • Cessation?
  • Ploom 2007
  • Pax Labs cannabis
slide-41
SLIDE 41

Tobacco Advertising

slide-42
SLIDE 42

Tobacco Advertising

slide-43
SLIDE 43
slide-44
SLIDE 44
slide-45
SLIDE 45
slide-46
SLIDE 46
slide-47
SLIDE 47

Point of Care Actions Screening

Brief Intervention Referral Treatment

slide-48
SLIDE 48
slide-49
SLIDE 49
slide-50
SLIDE 50
slide-51
SLIDE 51
slide-52
SLIDE 52
slide-53
SLIDE 53
slide-54
SLIDE 54
  • Risa Turetsky, MPH, FNP-C, PHN
slide-55
SLIDE 55

Resources

  • https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html
  • Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-

replacement therapy. N Engl J Med. 2019;380(7):629-637. doi:10.1056/NEJMoa1808779

  • Changing Perceptions of Harm of e-Cigarette vs Cigarette Use Among Adults in 2 US

National Surveys From 2012 to 2017; Jidong Huang, PhD1; Bo Feng, PhD2,3; Scott

  • R. Weaver, PhD4; et al
  • National Survey on Drug Use and Health (2016) – accessed via samhsa.gov
  • Remainder of sources are cited on the slides themselves